loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Venetoclax to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 12,343Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Nanjing Well Pharmaceutical

02 2Actylis

03 2Aeon Procare

04 1Alcedo Pharmachem

05 8BASF

06 4Finar

07 1Huzhou Sunflower Pharmaceutical

08 3Kerry

09 2Nomisma Healthcare

10 2Novo Excipients

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

02

arrow
AIChE Annual Meeting
Not Confirmed

04

arrow
AIChE Annual Meeting
Not Confirmed

05

arrow
AIChE Annual Meeting
Not Confirmed
arrow
AIChE Annual Meeting
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank

06

arrow
AIChE Annual Meeting
Not Confirmed
arrow
AIChE Annual Meeting
Not Confirmed
blank